Loss of Multimerin-2 and EMILIN-2 Expression in Gastric Cancer Associate with Altered Angiogenesis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of Multimerin-2 and EMILIN-2 Expression in Gastric Cancer Associate with Altered Angiogenesis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 12, Pages 3983
Publisher
MDPI AG
Online
2018-12-12
DOI
10.3390/ijms19123983
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
- (2018) Roberta Lugano et al. JOURNAL OF CLINICAL INVESTIGATION
- The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth
- (2018) Alice Paulitti et al. ONCOGENE
- Resveratrol inhibits the growth of gastric cancer via the Wnt/β-catenin pathway
- (2018) Hui Dai et al. Oncology Letters
- Candidate genes in gastric cancer identified by constructing a weighted gene co-expression network
- (2018) Jian Chen et al. PeerJ
- Emerging Therapies in the Management of Advanced-Stage Gastric Cancer
- (2018) Vivek Kumar et al. Frontiers in Pharmacology
- Angiogenesis inhibitors in early development for gastric cancer
- (2017) Mauricio P. Pinto et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis
- (2017) Eva Andreuzzi et al. MATRIX BIOLOGY
- Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium
- (2017) Federico Galvagni et al. MATRIX BIOLOGY
- Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface
- (2017) K A Khan et al. ONCOGENE
- Probe-based confocal laser endomicroscopy for in vivo evaluation of the tumor vasculature in gastric and rectal carcinomas
- (2017) Paola Spessotto et al. Scientific Reports
- Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
- (2016) Jin-Sung Park et al. CANCER CELL
- Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model
- (2016) E. Pivetta et al. CLINICAL SCIENCE
- Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2)
- (2016) Peter J. Noy et al. FASEB JOURNAL
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread
- (2015) Ping-Pui Wong et al. CANCER CELL
- Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience
- (2015) Roberto Petrioli et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- c-Met targeting in advanced gastric cancer: An open challenge
- (2015) Luigi Marano et al. CANCER LETTERS
- Bad vessels beware! Semaphorins will sort you out!
- (2015) G. Serini et al. EMBO Molecular Medicine
- Angiogenesis inhibitors in gastric and gastroesophageal junction cancer
- (2015) Giandomenico Roviello et al. Gastric Cancer
- Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains
- (2015) Simonetta Bot et al. MATRIX BIOLOGY
- MULTIMERIN2 binds VEGF-A primarily via the carbohydrate chains exerting an angiostatic function and impairing tumor growth
- (2015) Roberta Colladel et al. Oncotarget
- The Extracellular Matrix Glycoprotein Elastin Microfibril Interface Located Protein 2: A Dual Role in the Tumor Microenvironment
- (2015) Maurizio Mongiat et al. NEOPLASIA
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Unmet needs and challenges in gastric cancer: The way forward
- (2014) Florian Lordick et al. CANCER TREATMENT REVIEWS
- HER2 therapies and gastric cancer: A step forward
- (2014) Ramon Andrade de Mello WORLD JOURNAL OF GASTROENTEROLOGY
- Extracellular matrix protein 1 is correlated to carcinogenesis and lymphatic metastasis of human gastric cancer
- (2014) Qiuwan Wu et al. World Journal of Surgical Oncology
- EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration
- (2013) Stefano Marastoni et al. JOURNAL OF PATHOLOGY
- EMILIN1/α9β1 Integrin Interaction Is Crucial in Lymphatic Valve Formation and Maintenance
- (2013) Carla Danussi et al. MOLECULAR AND CELLULAR BIOLOGY
- Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
- (2012) Y. Y. Janjigian et al. ANNALS OF ONCOLOGY
- Vascular Smooth Muscle Emilin-1 Is a Regulator of Arteriolar Myogenic Response and Blood Pressure
- (2012) Gaia Litteri et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- An EMILIN1-Negative Microenvironment Promotes Tumor Cell Proliferation and Lymph Node Invasion
- (2012) C. Danussi et al. Cancer Prevention Research
- A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
- (2012) Niantao Deng et al. GUT
- Endomicroscopy and Cancer: A New Approach to the Visualization of Neoangiogenesis
- (2012) Renato Cannizzaro et al. Gastroenterology Research and Practice
- The EMILIN/Multimerin Family
- (2012) Alfonso Colombatti et al. Frontiers in Immunology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- EMILIN1–α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation
- (2011) Carla Danussi et al. JOURNAL OF CELL BIOLOGY
- MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway
- (2011) E Lorenzon et al. ONCOGENE
- Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer
- (2010) Shioto Suzuki et al. BMC CANCER
- Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial
- (2010) Alicia F.C. Okines et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer
- (2010) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Identification of 5 novel genes methylated in breast and other epithelial cancers
- (2010) Victoria K Hill et al. Molecular Cancer
- Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer
- (2008) S Rao et al. BRITISH JOURNAL OF CANCER
- Extracellular Matrix: A Matter of Life and Death
- (2008) Stefano Marastoni et al. CONNECTIVE TISSUE RESEARCH
- Locally Advanced and Metastatic Gastric Cancer
- (2008) Kathryn Field et al. DRUGS
- Emilin1 Deficiency Causes Structural and Functional Defects of Lymphatic Vasculature
- (2008) C. Danussi et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search